| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $49,032,860 ) (Continued on the next page) |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA046527 | Researching Effective Strategies to Prevent Opioid Death (RESPOND) | 001 | 9 | NIH | 7/27/2026 | $797,674 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01HL151902 | Building methods to assess and address cardiovascular health in transgender adults | 003 | 5 | NIH | 2/11/2026 | $166,277 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MH109651 | Elucidating mechanistic connections between guidance signaling, microtubule regulation, and growth cone steering | 001 | 10 | NIH | 9/2/2026 | $0 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MH109651 | Elucidating mechanistic connections between guidance signaling, microtubule regulation, and growth cone steering | 000 | 10 | NIH | 12/24/2025 | $435,369 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T32AI052074 | BU Clinical HIV/AIDS Research Training Program (BU-CHART) | 002 | 21 | NIH | 9/11/2026 | $473,644 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DA013582 | Clinical Addiction Research and Education (CARE) Program | 000 | 25 | NIH | 6/8/2026 | $365,780 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DA061939 | Community-Engaged Development of a Peer Breastfeeding Support Intervention for Mothers with Opioid Use Disorder | 000 | 2 | NIH | 1/30/2026 | $193,619 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R33DA059856 | Substance Use Prevention for Recently displaced Adults (SUPRA) | 001 | 3 | NIH | 3/3/2026 | $118,239 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AI198006 | Mycobacterium Tuberculosis impact on HIV reservoir Clearance (MyTHIC) | 000 | 1 | NIH | 5/4/2026 | $795,622 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R33DA059856 | Substance Use Prevention for Recently displaced Adults (SUPRA) | 000 | 3 | NIH | 2/26/2026 | $556,407 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AG093132 | Mosaic loss of the Y chromosome in transthyretin (ATTR) cardiac amyloidosis | 000 | 1 | NIH | 3/5/2026 | $763,561 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R33DA062217 | A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk | 000 | 2 | NIH | 7/30/2026 | $1,106,433 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | RM1DA066198 | PREP-TALK: Transforming Hospitalization into a PrEP Engagement Opportunity for People Who Use Drugs | 001 | 1 | NIH | 9/17/2026 | $0 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | RM1DA066198 | PREP-TALK: Transforming Hospitalization into a PrEP Engagement Opportunity for People Who Use Drugs | 000 | 1 | NIH | 7/20/2026 | $2,066,706 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AI191221 | TACTIC: Tuberculosis Active Case Tracking via Interpersonal Connections | 001 | 1 | NIH | 7/3/2026 | $296,010 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AI191221 | TACTIC: Tuberculosis Active Case Tracking via Interpersonal Connections | 000 | 1 | NIH | 6/19/2026 | $487,764 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MD019068 | Adapting an Evidence-Based Intervention to Improve the Hospital Discharge Process for Patients with Limited English Proficiency | 002 | 4 | NIH | 7/14/2026 | $0 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MD019068 | Adapting an Evidence-Based Intervention to Improve the Hospital Discharge Process for Patients with Limited English Proficiency | 001 | 4 | NIH | 6/19/2026 | $162,202 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K08HL177161 | Developing models of placenta-driven developmental lung injury in human preeclampsia | 000 | 2 | NIH | 8/19/2026 | $166,752 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R33DA060588 | Massachusetts HIV and Justice-Involved Populations Research Network | 000 | 4 | NIH | 8/5/2026 | $1,532,176 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DA059908 | Clinical Undergraduate Research in Addictions - Training and Experiences (CURATE) Program | 001 | 2 | NIH | 7/6/2026 | $132,507 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MH138549 | Adaptive interventions to improve posttraumatic stress (PTSD) treatment access, engagement, and effectiveness in routine care | 000 | 2 | NIH | 7/15/2026 | $863,400 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DA033211 | Advancing Clinical Research Training within Addiction Residency Programs | 000 | 13 | NIH | 2/18/2026 | $363,891 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK141016 | Role of Intravenous ultrasound (IVUS) in arteriovenous hemodialysis access dysfunction | 000 | 3 | NIH | 8/18/2026 | $759,459 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | UT953486 | Supporting Fetal Alcohol Spectrum Disorders (FASD) Screening and Intervention | 00 | 3 | HRSA | 8/6/2026 | $980,553 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AI186597 | The relationship between HIV exposure, contact networks, and TB in children under 5 years old | 000 | 3 | NIH | 7/22/2026 | $190,512 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | U01DK133092 | Boston Chronic Kidney Disease Research Biopsy Center | 000 | 5 | NIH | 7/16/2026 | $799,999 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H9E53185 | Transition for Youth with Autism and/or Epilepsy Demonstration Projects | 00 | 3 | HRSA | 7/24/2026 | $449,740 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HD115574 | Efficacy of Teleconsultation to Improve Prehospital Patient Safety for Critically Ill Infants and Children - A Multicenter, Simulation-based Randomized Control Trial | 001 | 3 | NIH | 8/20/2026 | $99,517 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HD115574 | Efficacy of Teleconsultation to Improve Prehospital Patient Safety for Critically Ill Infants and Children - A Multicenter, Simulation-based Randomized Control Trial | 000 | 3 | NIH | 8/7/2026 | $746,787 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK138309 | Effectiveness Trial to Support Adoption of Hybrid Closed Loop Therapy in Underserved Adults with Type 1 Diabetes: Impact of System Functionality and Features on Lived Experience | 000 | 3 | NIH | 1/28/2026 | $844,525 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T32MH135857 | Boston University Medical Campus- Massachusetts General Hospital Global Psychiatric Clinical Research Training Program | 000 | 3 | NIH | 6/23/2026 | $358,488 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01NS128342 | Addressing an Inherent Bias in Neuroprognostication: A Collaboration Between the US and Brazil to Reduce the Impact of Self-Fulfilling Prophecy in Cardiac ARrEst (SPARE) | 003 | 3 | NIH | 3/3/2026 | $25,758 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01NS128342 | Addressing an Inherent Bias in Neuroprognostication: A Collaboration Between the US and Brazil to Reduce the Impact of Self-Fulfilling Prophecy in Cardiac ARrEst (SPARE) | 002 | 3 | NIH | 3/2/2026 | $25,758 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01NS128342 | Addressing an Inherent Bias in Neuroprognostication: A Collaboration Between the US and Brazil to Reduce the Impact of Self-Fulfilling Prophecy in Cardiac ARrEst (SPARE) | 001 | 3 | NIH | 2/27/2026 | $25,758 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01NS128342 | Addressing an Inherent Bias in Neuroprognostication: A Collaboration Between the US and Brazil to Reduce the Impact of Self-Fulfilling Prophecy in Cardiac ARrEst (SPARE) | 000 | 3 | NIH | 2/20/2026 | $478,045 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01NS128342 | Addressing an Inherent Bias in Neuroprognostication: A Collaboration Between the US and Brazil to Reduce the Impact of Self-Fulfilling Prophecy in Cardiac ARrEst (SPARE) | 004 | 3 | NIH | 3/4/2026 | $25,758 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01AI167733 | Nutritional Interventions to End Tuberculosis among Persons with HIV (NUTRIENT) | 000 | 4 | NIH | 9/10/2026 | $128,391 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | NU01DD000016 | Component A; Opioid Use Disorder in Pregnancy and Neonatal Opioid Withdrawal Syndrome Longitudinal Surveillance Project | 00 | 4 | CDC | 8/24/2026 | $499,646 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T2554939 | Addiction Medicine Fellowship | 01 | 2 | HRSA | 6/30/2026 | $0 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T2554939 | Addiction Medicine Fellowship | 00 | 2 | HRSA | 5/21/2026 | $799,517 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | M0154849 | Behavioral Health Workforce Education and Training Program | 00 | 2 | HRSA | 6/4/2026 | $599,853 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DA052821 | Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV) | 000 | 5 | NIH | 7/10/2026 | $189,216 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL166606 | Targeting Energetics to Improve Outcomes in Hypertrophic Cardiomyopathy | 001 | 3 | NIH | 3/13/2026 | $23,581 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL166606 | Targeting Energetics to Improve Outcomes in Hypertrophic Cardiomyopathy | 000 | 3 | NIH | 3/9/2026 | $746,783 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DK136973 | Deep learning approach for the assessment of arterial and arteriolar lesions in kidney biopsies and prediction of cardiovascular risk | 000 | 3 | NIH | 8/12/2026 | $151,780 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK146149 | First person storytelling: Improving kidney education for Spanish speakers with advanced kidney disease | 001 | 1 | NIH | 7/15/2026 | $0 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK146149 | First person storytelling: Improving kidney education for Spanish speakers with advanced kidney disease | 000 | 1 | NIH | 1/26/2026 | $194,147 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R03CA308637 | Personalized Spatial Regulatory Networks to Decode Breast Cancer Microenvironments | 000 | 1 | NIH | 6/12/2026 | $178,000 |
|
